Shares of Honda India Power and HLE Glascoat were locked in a 20 per cent upper circuit on Tuesday after their profit doubled in Q4FY25 ...

Pfizer stated that the drug candidate, which is being evaluated for non-small cell lung cancer, metastatic colorectal cancer ...

NBCC: The company has successfully sold 446 residential units at Aspire Silicon City in Noida through an e-auction, generating Rs 1,468 crore in sales. Additionally, it will receive a marketing fee of ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Foreign portfolio investors remained net buyers of Indian equities for the third straight day on Friday, as they mopped up equities worth Rs 8,831.1 crore, the highest since March 27, according to the ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

May 14, 2025 Alnylam drops Covid vaccine patent case against Pfizer, BioNTech for now Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over ...

Discover what's behind Pfizer's sharp decline, from post-pandemic revenue drops to halted drug development and regulatory ...

Pfizer can cover its dividends with free cash flow, but doesn't have a huge cushion. The company faces some risks from ...

It looks like Pfizer Inc. ( NYSE:PFE ) is about to go ex-dividend in the next two days. The ex-dividend date is ...

Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US. Albery Bourla said there could be "tremendous investments" in R&D and manufacturing in the US ...